Leeds researchers have been awarded a £10.1 million investment from UK Research and Innovation to expand a digital pathology and artificial intelligence programme across the North of England. FFEI, which create cutting-edge digital medical imaging technology, image quality and colour accuracy solutions, providing data optimal for AI diagnosis, welcomed the announcement of national funding that will allow the creation of a digital pathology clinical network and research programme.
The successful partnership bid, led by the University of Leeds and Leeds Teaching Hospitals, includes FFEI in a network of nine NHS hospitals, seven universities and 10 industry-leading medical technology companies, called the Northern Pathology Imaging Co-operative (NPIC).
The investment of £10.1 million from UK Research and Innovation is boosted by an initial investment of £7 million from the companies involved in the programme. The consortium is now set to become a globally-leading centre for applying artificial intelligence (AI) research to cancer diagnosis.